Abstract
Progression in the central nervous system (CNS) has become the major life-limiting problem for breast cancer patients since most drugs are ineffective because the brain is protected by the blood-brain barrier. In the present study, we sought to investigate the association between molecular subtypes and the treatment outcome of breast cancer patients with brain metastases after whole brain radiation therapy (WBRT).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
